Guilbaud N - Search Results

1

The DNA-Binding Polyamine Moiety in the Vectorized DNA Topoisomerase II Inhibitor F14512 Alters Reparability of the Consequent Enzyme-Linked DNA Double-Strand Breaks.

Bombarde O, Larminat F, Gomez D, Frit P, Racca C, Gomes B, Guilbaud N, Calsou P. Bombarde O, et al. Among authors: guilbaud n. Mol Cancer Ther. 2017 Oct;16(10):2166-2177. doi: 10.1158/1535-7163.MCT-16-0767. Epub 2017 Jun 13. Mol Cancer Ther. 2017. PMID: 28611105

2

F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity.

Kruczynski A, Pillon A, Créancier L, Vandenberghe I, Gomes B, Brel V, Fournier E, Annereau JP, Currie E, Guminski Y, Bonnet D, Bailly C, Guilbaud N. Kruczynski A, et al. Among authors: guilbaud n. Leukemia. 2013 Nov;27(11):2139-48. doi: 10.1038/leu.2013.108. Epub 2013 Apr 9. Leukemia. 2013. PMID: 23568148

3

Phase I Clinical Pharmacology Study of F14512, a New Polyamine-Vectorized Anticancer Drug, in Naturally Occurring Canine Lymphoma.

Tierny D, Serres F, Segaoula Z, Bemelmans I, Bouchaert E, Pétain A, Brel V, Couffin S, Marchal T, Nguyen L, Thuru X, Ferré P, Guilbaud N, Gomes B. Tierny D, et al. Among authors: guilbaud n. Clin Cancer Res. 2015 Dec 1;21(23):5314-23. doi: 10.1158/1078-0432.CCR-14-3174. Epub 2015 Jul 13. Clin Cancer Res. 2015. PMID: 26169968 Clinical Trial.

4

F14512, a polyamine-vectorized inhibitor of topoisomerase II, exhibits a marked anti-tumor activity in ovarian cancer.

Thibault B, Clement E, Zorza G, Meignan S, Delord JP, Couderc B, Bailly C, Narducci F, Vandenberghe I, Kruczynski A, Guilbaud N, Ferré P, Annereau JP. Thibault B, et al. Among authors: guilbaud n. Cancer Lett. 2016 Jan 1;370(1):10-8. doi: 10.1016/j.canlet.2015.09.006. Epub 2015 Sep 25. Cancer Lett. 2016. PMID: 26404751

5

F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system.

Barret JM, Kruczynski A, Vispé S, Annereau JP, Brel V, Guminski Y, Delcros JG, Lansiaux A, Guilbaud N, Imbert T, Bailly C. Barret JM, et al. Among authors: guilbaud n. Cancer Res. 2008 Dec 1;68(23):9845-53. doi: 10.1158/0008-5472.CAN-08-2748. Cancer Res. 2008. PMID: 19047165

6

Cytotoxicity and cell death mechanisms induced by the polyamine-vectorized anti-cancer drug F14512 targeting topoisomerase II.

Brel V, Annereau JP, Vispé S, Kruczynski A, Bailly C, Guilbaud N. Brel V, et al. Among authors: guilbaud n. Biochem Pharmacol. 2011 Dec 15;82(12):1843-52. doi: 10.1016/j.bcp.2011.08.028. Epub 2011 Sep 8. Biochem Pharmacol. 2011. PMID: 21924246

7

Randomized, double-blind trial of F14512, a polyamine-vectorized anticancer drug, compared with etoposide phosphate, in dogs with naturally occurring lymphoma.

Boyé P, Floch F, Serres F, Segaoula Z, Hordeaux J, Pascal Q, Coste V, Courapied S, Bouchaert E, Rybicka A, Mazuy C, Marescaux L, Geeraert K, Fournel-Fleury C, Duhamel A, Machuron F, Ferré P, Pétain A, Guilbaud N, Tierny D, Gomes B. Boyé P, et al. Among authors: guilbaud n. Oncotarget. 2020 Feb 18;11(7):671-686. doi: 10.18632/oncotarget.27461. eCollection 2020 Feb 18. Oncotarget. 2020. PMID: 32133044 Free PMC article.

8

An integrated Drosophila model system reveals unique properties for F14512, a novel polyamine-containing anticancer drug that targets topoisomerase II.

Chelouah S, Monod-Wissler C, Bailly C, Barret JM, Guilbaud N, Vispé S, Käs E. Chelouah S, et al. Among authors: guilbaud n. PLoS One. 2011;6(8):e23597. doi: 10.1371/journal.pone.0023597. Epub 2011 Aug 10. PLoS One. 2011. PMID: 21853156 Free PMC article.

9

Discovery bioanalysis and in vivo pharmacology as an integrated process: a case study in oncology drug discovery.

Grondin A, Pillon A, Vandenberghe I, Guilbaud N, Kruczynski A, Gomes B. Grondin A, et al. Among authors: guilbaud n. Bioanalysis. 2016 Jul;8(14):1481-98. doi: 10.4155/bio-2016-0062. Epub 2016 Jun 17. Bioanalysis. 2016. PMID: 27314564

10

Actinic keratosis modelling in mice: A translational study.

Pillon A, Gomes B, Vandenberghe I, Cartron V, Cèbe P, Blanchet JC, Sibaud V, Guilbaud N, Audoly L, Lamant L, Kruczynski A. Pillon A, et al. Among authors: guilbaud n. PLoS One. 2017 Jun 29;12(6):e0179991. doi: 10.1371/journal.pone.0179991. eCollection 2017. PLoS One. 2017. PMID: 28662116 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page